Properties (66)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
chemical compound
|
| gptkbp:chemicalFormula |
C12H15N3O2
|
| gptkbp:hasAwards |
serotonin receptors
|
| gptkbp:hasFilm |
dizziness
nausea |
| gptkbp:hasWeight |
233.27 g/mol
|
| https://www.w3.org/2000/01/rdf-schema#label |
WPC-1272
|
| gptkbp:isAssociatedWith |
improved mood
|
| gptkbp:isAttendedBy |
gptkb:FDA
clinical settings oral tablet |
| gptkbp:isAvailableIn |
various dosages
|
| gptkbp:isAvenueFor |
pharmacokinetics
|
| gptkbp:isCompatibleWith |
room temperature
|
| gptkbp:isConsidered |
treatment protocols
treatment guidelines safe for use clinical application first-line treatment off-label use |
| gptkbp:isDiscussedIn |
medical conferences
|
| gptkbp:isDocumentedIn |
medical literature
pharmaceutical databases clinical trials registry |
| gptkbp:isEvaluatedBy |
patient compliance
therapeutic index long-term efficacy adverse reactions |
| gptkbp:isImportantFor |
quality of life
|
| gptkbp:isLinkedTo |
neurotransmitter modulation
|
| gptkbp:isMarketedAs |
brand name A
|
| gptkbp:isNotedFor |
low side effect profile
|
| gptkbp:isPartOf |
clinical trials
mental health treatment treatment regimen other medications mental health research clinical practice. drug development pipeline mental health pharmacotherapy |
| gptkbp:isPortrayedBy |
clinical guidelines
antidepressant effects |
| gptkbp:isRecognizedFor |
major depressive disorder
|
| gptkbp:isReflectedIn |
therapeutic outcomes
|
| gptkbp:isRelatedTo |
antidepressant drugs
|
| gptkbp:isStudiedIn |
animal models
cognitive function anxiety disorders pharmacodynamics neuropsychiatric disorders |
| gptkbp:isSubjectTo |
regulatory review
|
| gptkbp:isSuitableFor |
precursor compounds
|
| gptkbp:isSupportedBy |
mental health recovery
|
| gptkbp:isTrainedIn |
placebo
|
| gptkbp:isUsedBy |
healthcare_professionals
|
| gptkbp:isUsedFor |
other antidepressants
|
| gptkbp:isUsedIn |
pharmaceutical applications
psychotherapy adjuncts |
| gptkbp:isUtilizedFor |
bipolar disorder
patient populations co-morbid conditions treatment-resistant depression |
| gptkbp:isUtilizedIn |
randomized controlled trials
real-world settings |
| gptkbp:isVisitedBy |
gptkb:XYZ_Pharmaceuticals
|
| gptkbp:numberOfFigures |
123456-78-9
|